PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11060901-4	2000	N-tosyl-L-phenylalanine chloromethyl ketone (TPCK), a PAF synthesis inhibitor, and manoalide, a phospholipase A2 inhibitor, reduced 12(R)-HETE-induced [Ca2+]i rise.	Tosylphenylalanyl Chloromethyl Ketone	0-43	PCNA clamp associated factor	Homo sapiens	54-57	
1848228-7	1991	In addition, the serine protease inhibitor L-1-tosylamide-2-phenylethyl chloromethyl ketone, which inhibits PAF synthesis, reduced PAF accumulation as well as superoxide generation, raising the possibility of a causal relationship between cell-associated PAF and cell activation.	Tosylphenylalanyl Chloromethyl Ketone	43-91	PCNA clamp associated factor	Homo sapiens	108-111	
1848228-7	1991	In addition, the serine protease inhibitor L-1-tosylamide-2-phenylethyl chloromethyl ketone, which inhibits PAF synthesis, reduced PAF accumulation as well as superoxide generation, raising the possibility of a causal relationship between cell-associated PAF and cell activation.	Tosylphenylalanyl Chloromethyl Ketone	43-91	PCNA clamp associated factor	Homo sapiens	131-134	
1848228-7	1991	In addition, the serine protease inhibitor L-1-tosylamide-2-phenylethyl chloromethyl ketone, which inhibits PAF synthesis, reduced PAF accumulation as well as superoxide generation, raising the possibility of a causal relationship between cell-associated PAF and cell activation.	Tosylphenylalanyl Chloromethyl Ketone	43-91	PCNA clamp associated factor	Homo sapiens	131-134